Journeying to Ixtlan: Ethics of Psychedelic Medicine and Research for Alzheimer’s Disease and Related Dementias-Reference-Cited by-同舟云学术

Journeying to Ixtlan: Ethics of Psychedelic Medicine and Research for Alzheimer’s Disease and Related Dementias

Published:2022-12-08 Issue:2 Volume:14 Page:107-123
ISSN:2150-7740
Container-title:AJOB Neuroscience
language:en
Short-container-title:AJOB Neuroscience

Author:

Peterson Andrew¹^ORCID,Largent Emily A.²^ORCID,Lynch Holly Fernandez²^ORCID,Karlawish Jason²,Sisti Dominic²^ORCID

Affiliation:

1. George Mason University

2. University of Pennsylvania Perelman School of Medicine

Funder

National Institute on Aging

Publisher

Informa UK Limited

Subject

General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/21507740.2022.2148771

Reference118 articles.

1. Long-term effects of psychedelic drugs: A systematic review

2. Research Consent for Cognitively Impaired Adults

3. American Bar Association, Commission on Law and Aging & American Psychological Association. 2021. Assessment of older adults with diminished capacity. 2nd ed. Accessed March 27, 2022. https://www.apa.org/pi/aging/resources/guides/diminished-capacity.pdf.

4. Psychedelic medicine: safety and ethical concerns

5. Association Between Spousal Caregiver Well-Being and Care Recipient Healthcare Expenditures

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Responding to existential distress at the end of life: Psychedelics and psychedelic experiences and/ as medicine;Neuroethics;2024-08-24

2. Transformative Experience;Philosophy Compass;2024-06

3. Choosing Suggested Integration Goals;EMBARK Psychedelic Therapy for Depression;2024-04-23

4. Working Within the EMBARK Domains Cheat Sheet;EMBARK Psychedelic Therapy for Depression;2024-04-23

5. Medicine Sessions;EMBARK Psychedelic Therapy for Depression;2024-04-23